|
|||
|
Emergent BioSolutions has a proven track record as a world-class provider of contract manufacturing services for both bulk drug substances and sterile injectable drug products. Our state-of-the-art single-use BDS facility enables turnkey upstream and downstream support for mammalian, microbial, avian, insect and viral cell lines. For sterile injectable drug products, our service offering includes vials, syringes; liquid and lyophilized products. We currently produce 20 commercial products and have supported the development/manufacture of more than 200 clinical candidates for our clients. Our facility has been inspected by a host of regulatory agencies worldwide, including the US, EU and Japan. Visit Emergent BioSolutions at the Interphex Conference |
|||
|
|||
 
|
|||
|
|||
|
|||
|
